News
11-25-2010, 12:32 AM
About 30% of breast cancer patients have tumours that show rapid growth and invasion through the body. A common denominator in all of these cases is the presence of a large number of Her2 proteins in tumour cellular membranes. Consequently, these aggressive tumours are referred to as HER2+. Scientists working in the Metastasis Laboratory (MetLab) at IRB Barcelona headed by ICREA researcher Roger Gomis, have described the molecular mechanism that induces HER2+ tumours to ignore the signals that protect cells from excessive growth.
More... (http://www.news-medical.net/news/20101125/Researchers-explain-molecular-mechanism-that-induces-HER22b-tumours-to-ignore-cell-signals.aspx)
More... (http://www.news-medical.net/news/20101125/Researchers-explain-molecular-mechanism-that-induces-HER22b-tumours-to-ignore-cell-signals.aspx)